Senior Manager, Accounting

BlueRock Therapeutics, a wholly-owned and independently operated subsidiary of Bayer AG, is a leading engineered cell therapy company pioneering a new generation of cellular medicines. Utilizing our proprietary CELL+GENE™ platform, we direct cellular differentiation and genetically engineer cells to create transformative therapies for patients suffering from neurological and ophthalmological diseases.

Founded in 2016, BlueRock is at the forefront of the convergence of cell biology and genetic engineering. Our mission is to harness pluripotent stem cell technology and gene editing to deliver authentic, functional cell therapies that address the root causes of disease and offer hope to millions of patients worldwide.

What Are We Doing?

Our foundational science enables the generation and directed differentiation of universal pluripotent stem cells into authentic, functional cells for allogeneic cellular therapies.

We are passionate about realizing the promise of cell and gene therapy, shaping the future of regenerative medicine, and delivering new therapies to patients with limited or no treatment options.

The Senior Manager, Accounting will be responsible for managing many aspects of Bluerock’s Accounting Operations process. This role will report to the Director of Accounting and will take ownership of the company’s daily accounting transactions that impact the General Ledger.

This position is expected to have advance understanding of all data points that feed the General Ledger while being able to identify and troubleshoot reporting needs. The position is also responsible for owning all Month-end/Quarter-end/Year-end close related tasks. This role will be expected to partner closely with parties within and outside of finance to understand Bluerock’s operations and ensure the timely and accurate delivery of financial results to management.

This is a hands-on managerial position in which the ability to multitask, take initiative, pay meticulous attention to details, manage staff, and work well with others is essential. The successful candidate will be someone who proves to be a strong

and multifaceted performer who can meet crucial deadlines. They must also be proficient at identifying, understanding and adopting new accounting rules (US GAAP & IFRS) and the ability to enforce of internal control matrix

Responsibilities:

· Manage General Ledger accounting and the lead aspects of monthly/quarterly/year-end close, including preparing/reviewing journal entries and account reconciliations.

· Monitor and maintain ERP system modules, including managing accounting close processes and deadlines.

· Participate in preparation of internal and external financial statements.

· Provide support for annual financial statement audits.

· Assist with building and maintaining a strong internal control environment.

· Contribute to system implementations and other special projects.

Minimum Requirements:

· Bachelor’s degree in accounting and 7+ years of accounting experience.

· Strong analytical, problem-solving skills and collaborative skills.

· Must be able to make judgment calls, troubleshoot and problem resolutions.

· Excellent verbal and written communication skills.

Equal Opportunity Workplace: At BlueRock, we welcome and support differences and diversity and we are proud to be an equal opportunity workplace. Please let us know if you require disability-related accommodation or other grounds protected by human rights legislation during the recruitment process so that we can work with you to meet your needs.

We may use artificial intelligence (AI) tools to support parts of the hiring process, such as reviewing applications, analyzing resumes, or assessing responses. These tools assist our recruitment team but do not replace human judgment. Final hiring decisions are ultimately made by humans. If you would like more information about how your data is processed, please contact us.

About Us

BlueRock Therapeutics is a clinical stage cell therapy company focused on creating cellular medicines to treat devastating diseases. We are harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, one for the treatment of Parkinson’s disease and one for the treatment of primary photoreceptor diseases, are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer, the impact investing arm of Bayer AG that invests in paradigm-shifting breakthrough innovation. In late 2019, BlueRock became a wholly owned, independently operated subsidiary of Bayer AG. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.